Silence Therapeutics (SLN) Health Care Sector

  • Latest quote

    59.00p (mid)

  • Current Change (%)

    3.03%

  • Price

    Bid: 58.00p

    Offer: 59.50p

  • Today

    High: 59.50p

    Low: 59.50p

  • This year

    High: 173.50p

    Low: 41.00p

  • Information

    Volume: 30,875

    Market Cap: £41.89M




Silence Therapeutics RNS Feed

Title Release date
Silence Therapeutics Publication of Annual Report 07:00 - April 18, 2019
Appointment of Chief Financial Officer 07:00 - April 18, 2019
Silence Therapeutics Announces Board Change 11:00 - April 16, 2019
Silence Therapeutics appoints Head of R&D and CMO 07:00 - April 16, 2019
Silence Therapeutics submits CTA for SLN124 07:00 - March 27, 2019
2018 Preliminary Results 07:00 - March 11, 2019
Silence to Present at Cowen Healthcare Conference 07:00 - March 7, 2019
Notice of Results 07:00 - March 5, 2019
Second Price Monitoring Extn 16:40 - February 1, 2019
Price Monitoring Extension 16:35 - February 1, 2019
SLN124 granted Orphan Drug Designation by EMA 07:00 - January 15, 2019
Departure of Chief Financial Officer 07:00 - January 9, 2019
Silence Therapeutics advances next RNAi medicine 07:00 - December 19, 2018
Price Monitoring Extension 16:35 - December 18, 2018
Settlement and License Agreement with Alnylam 07:00 - December 10, 2018

NOTE: This is based on 1 open tips for this company


Total Number of Share tips :

24

View all Silence Therapeutics Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today